<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MeisenMeister: A Simple Two Stage Pipeline for Breast Cancer Classification on MRI - Health AI Hub</title>
    <meta name="description" content="This paper presents "MeisenMeister," a simple two-stage pipeline for breast cancer classification on MRI, developed for the ODELIA Breast MRI Challenge 2025. It">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>MeisenMeister: A Simple Two Stage Pipeline for Breast Cancer Classification on MRI</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2510.27326v1" target="_blank">2510.27326v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-10-31
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Benjamin Hamm, Yannick Kirchhoff, Maximilian Rokuss, Klaus Maier-Hein
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2510.27326v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2510.27326v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper presents "MeisenMeister," a simple two-stage pipeline for breast cancer classification on MRI, developed for the ODELIA Breast MRI Challenge 2025. It addresses the critical need for robust classification-based approaches to improve early breast cancer detection, particularly in large-scale screening, given the scarcity of high-quality segmentation labels in breast MRI.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is highly relevant to medicine as it aims to significantly improve the accuracy and efficiency of early breast cancer detection through MRI, a critical factor for patient prognosis and treatment outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper describes a two-stage pipeline, 'MeisenMeister', which is an AI (likely machine learning/deep learning) classification-based approach designed to interpret breast MRI scans for the purpose of detecting breast cancer. This application aims to improve the efficiency and accuracy of early breast cancer detection, particularly in large-scale screening programs, thereby assisting clinicians in diagnosis and potentially improving patient outcomes.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the ODELIA Breast MRI Challenge 2025, focusing on enhancing early breast cancer detection through improved MRI interpretation.</li>
                    
                    <li>Highlights the significant challenge of limited high-quality segmentation labels for breast MRI, necessitating robust classification-based methods.</li>
                    
                    <li>Proposes a 'simple two-stage pipeline' named MeisenMeister designed for breast cancer classification.</li>
                    
                    <li>Details an iterative development process involving experimentation, evaluation, and refinement that shaped the solution.</li>
                    
                    <li>The final submission's design choices were informed by reasoning and evidence prioritizing performance, robustness, and clinical relevance.</li>
                    
                    <li>The methodology aims to be crucial for the future of early breast cancer detection, particularly in large-scale screening applications.</li>
                    
                    <li>The full implementation of MeisenMeister is publicly released on GitHub for reproducibility and further research.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The authors propose MeisenMeister, a 'simple two-stage pipeline' for breast cancer classification on MRI. The development process was iterative, involving stages of experimentation, evaluation, and refinement. While the abstract does not detail the specific technical components of the pipeline, it emphasizes a classification-based approach designed to be robust and clinically relevant, circumventing the need for extensive high-quality segmentation labels.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The abstract outlines the rationale behind the design of the MeisenMeister pipeline, emphasizing that its architecture and parameters were determined through an iterative development process. This process led to design choices informed by evidence and reasoning, focusing on achieving high performance, robustness against real-world variability, and strong clinical relevance for breast cancer detection.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The potential clinical impact is substantial: more efficient and accurate interpretation of breast MRI scans, leading to earlier and more reliable detection of breast cancer. This is particularly valuable for large-scale screening programs, where automated and robust classification can alleviate radiologist workload and improve diagnostic consistency, ultimately enhancing patient care and outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state limitations of the MeisenMeister approach itself. However, it highlights a foundational challenge in the field ‚Äì the 'limited availability of high-quality segmentation labels' ‚Äì which their classification-based approach is specifically designed to overcome.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly detailing future research steps for their specific work, the authors state that developing robust classification-based approaches, like theirs, is 'crucial for the future of early breast cancer detection, particularly in applications such as large-scale screening,' implying a broader impact and ongoing need for such research.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Diagnostic Radiology</span>
                    
                    <span class="tag">Medical Imaging</span>
                    
                    <span class="tag">Preventive Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Breast Cancer</span>
                    
                    <span class="tag tag-keyword">MRI</span>
                    
                    <span class="tag tag-keyword">Classification</span>
                    
                    <span class="tag tag-keyword">Early Detection</span>
                    
                    <span class="tag tag-keyword">Medical Imaging</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                    <span class="tag tag-keyword">ODELIA Challenge</span>
                    
                    <span class="tag tag-keyword">Screening</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The ODELIA Breast MRI Challenge 2025 addresses a critical issue in breast
cancer screening: improving early detection through more efficient and accurate
interpretation of breast MRI scans. Even though methods for general-purpose
whole-body lesion segmentation as well as multi-time-point analysis exist,
breast cancer detection remains highly challenging, largely due to the limited
availability of high-quality segmentation labels. Therefore, developing robust
classification-based approaches is crucial for the future of early breast
cancer detection, particularly in applications such as large-scale screening.
In this write-up, we provide a comprehensive overview of our approach to the
challenge. We begin by detailing the underlying concept and foundational
assumptions that guided our work. We then describe the iterative development
process, highlighting the key stages of experimentation, evaluation, and
refinement that shaped the evolution of our solution. Finally, we present the
reasoning and evidence that informed the design choices behind our final
submission, with a focus on performance, robustness, and clinical relevance. We
release our full implementation publicly at
https://github.com/MIC-DKFZ/MeisenMeister</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Winning Solution of the MICCAI 2025 ODELIA Breast MRI Classification
  Challenge</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>